Cristal Therapeutics   Report issue

For profit Phase 2
Founded: Maastricht Netherlands (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2015
NCT02442531
First Marketed Drug
2018
oxygen
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

CRISTAL ASU LLC | Cristal Therapeutics